This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Phytonadione

Read time: 1 mins
Marketing start date: 18 Nov 2024

Summary of product characteristics


Effective Time

20221101

Version

6

Spl Product Data Elements

Phytonadione Phytonadione PHYTONADIONE PHYTONADIONE CELLULOSE, MICROCRYSTALLINE CROSCARMELLOSE SODIUM HYDROXYPROPYL CELLULOSE (110000 WAMW) LACTOSE MONOHYDRATE MAGNESIUM STEARATE SILICON DIOXIDE LIGHT YELLOW TO YELLOW ROUND 1014

Application Number

ANDA210189

Brand Name

Phytonadione

Generic Name

Phytonadione

Product Ndc

70771-1318

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Phytonadione Tablets USP, 5 mg 100 tablets NDC 70771-1318-1 Rx only label

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.